dihexa orally active Peptide Dihexa Peptide Therapy | Memory

Chemical & Handling Information Type: Synthetic FOXO4-interacting peptide analog Peptide length: Short peptide (exact sequence per specification/lot) Appearance: White to off-white lyophilized powder Specifications Peptide: FOXO4-DRI Amount: 5 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)

In Boyden chamber assays, TB4 stimulated keratinocyte migration 23-fold over medium alone within 45 hours with as little as 10 pg sufficient to produce a potent stimulatory response

For details on it (including licensing), click here

Funding Open access funding provided by the National Institutes of Health

Who Should NOT Use Peptides Pregnant or breastfeeding women Active cancer patients (some peptides may stimulate cell growth) People with certain autoimmune conditions Anyone without proper medical supervision Bottom line : Peptide therapy is safe when you work with qualified providers who understand proper dosing and monitoring